Edgar Gonzalez-Kozlova
@edgargk.bsky.social
๐ค 25
๐ฅ 17
๐ 4
Scientist/Explorer. Computational Biologist and Assistant Prof. at Sinai Immunology & Immunotherapy.
pinned post!
Scientists are working to shift from federal funding to state funding to facilitate identifying cures for multiple diseases with less bureaucracy. The first of its kind initiative 'Cures' New York State, register for free with your personal email !
nycures.org#support
5 months ago
0
1
0
reposted by
Edgar Gonzalez-Kozlova
Sinai Immuno
3 months ago
New **RESOURCE** in
@natcancer.nature.com
- a landmark single-cell Immune Atlas of multiple myelomaโ1.3M+ bone marrow cells from 337 patients. Led by the Immune Atlas Consortium with major contributions from Sacha Gnjatic,
@edgargk.bsky.social
& HIMC profiling teams ๐ง
www.nature.com/articles/s43...
1
7
4
reposted by
Edgar Gonzalez-Kozlova
NY-CURES
7 months ago
๐ NY-CURES Launch โ Championing State-Wide Investment in Science! ๐ Our new coalition advocates for sustained public support of New Yorkโs vibrant biomedical research ecosystem โ creating cures, economic gains & strengthening communities. Sign up. Stay informed. Join the movement:
www.nycures.org/
4
47
61
Scientists are working to shift from federal funding to state funding to facilitate identifying cures for multiple diseases with less bureaucracy. The first of its kind initiative 'Cures' New York State, register for free with your personal email !
nycures.org#support
5 months ago
0
1
0
reposted by
Edgar Gonzalez-Kozlova
Hank Green
5 months ago
What politician wants this: โMeals on Wheels x 100 with young people paid to cook and deliver meals.โ
42
1006
64
I'm excited to have been part of the correlative study for clinical trial NCT03576612 GMCI, Nivolumab, and Radiation Therapy in Treating Patients with Newly Diagnosed High-Grade Gliomas in a multicenter effort
pubmed.ncbi.nlm.nih.gov/40120123/
@sinaiimmuno.bsky.social
@GnjaticLab
loading . . .
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma - PubMed
These findings suggest the opportunity for patient stratification and the potential for more durable antitumor immune responses in future clinical trials of this multimodal standard of care and combin...
https://pubmed.ncbi.nlm.nih.gov/40120123/
about 1 year ago
0
3
1
Fantastic Webinar series on Current Immuno-Oncology advances and includes outstanding Professors such as Sacha Gnjatic from
@sinaiimmuno.bsky.social
!
about 1 year ago
0
3
3
Read about one of recent studies about discovery of new biomarkers to improve treatment and diagnostics of endometrial cancer!
@sinaiimmuno.bsky.social
www.mountsinai.org/about/newsro...
about 1 year ago
0
1
0
you reached the end!!
feeds!
log in